Carregant...
Large-scale drug screens support precision medicine
The major challenge underlying the emerging precision medicine initiative is to make links between cancer subsets and drugs that can be used to guide treatment of individual patients leading to improved outcomes and decreased toxicity. Schreiber et al [1] support this effort by reporting measurement...
Guardat en:
| Publicat a: | Cancer Discov |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2015
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4633700/ https://ncbi.nlm.nih.gov/pubmed/26526695 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/2159-8290.CD-15-0945 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|